BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 23, 2003
View Archived Issues
Genentech, Tanox Receive FDA Approval For Asthma Therapeutic
Genentech Inc. and partners Tanox Inc. and Novartis Pharma AG said late Friday the FDA approved Xolair, a first-in-class monoclonal antibody for moderate to severe persistent asthma in adults and adolescents. (BioWorld Today)
Read More
President Bush Among Headliners At BIO Conference In Washington
Read More
Genetically Tinkered Coffee Beans Produce Decaffeinated Brew Minus Alkaloid's Undesirable Side Effects
Read More
Discovery Laboratories Raises $27.M To Advance Surfactant
Read More
Hollis-Eden Raises $15M Via Private Placement Of Stock
Read More
Other News To Note
Read More